These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 12721924)

  • 41. Tenth informal consultation on the global polio laboratory network, 6-8 September 2004.
    Can Commun Dis Rep; 2004 Nov; 30(21):185-7. PubMed ID: 15554332
    [No Abstract]   [Full Text] [Related]  

  • 42. Progressing towards laboratory accreditation in developing countries.
    Young DS
    Afr J Med Med Sci; 2010 Dec; 39(4):333-40. PubMed ID: 21736001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measles surveillance: guidelines for laboratory support. Working Group on Measles Elimination.
    Carlson J; Artsob H; Douville-Fradet M; Duclos P; Fearon M; Ratnam S; Tipples G; Varughese P; Ward B; Sciberras J
    Can Commun Dis Rep; 1998 Mar; 24(5):33-44. PubMed ID: 9577061
    [No Abstract]   [Full Text] [Related]  

  • 44. Quality control and quality assurance.
    Laessig RH; Ehrmeyer SS; Hassemer DJ
    Clin Lab Med; 1986 Jun; 6(2):317-27. PubMed ID: 3720254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis on running status of Guizhou Provincial Measles Laboratory Network in 2007].
    Wu SW; Ye XF; Zhang L
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):112-4. PubMed ID: 20077653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How Can We Identify the Elimination of Infectious Diseases? Experience From an Active Measles Laboratory Surveillance System in the Republic of Korea.
    Yang TU; Kang HJ; Eom HE; Park YJ; Park O; Kim SJ; Nam JG; Kim SS; Jeong EK
    Asia Pac J Public Health; 2015 Nov; 27(8 Suppl):101S-109S. PubMed ID: 26023151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global measles and rubella laboratory network--update.
    World Health Organization
    Wkly Epidemiol Rec; 2005 Nov; 80(44):384-8. PubMed ID: 16300026
    [No Abstract]   [Full Text] [Related]  

  • 49. [Standardization in clinical laboratory--its national and international activities].
    Kawai T
    Rinsho Byori; 1993 Apr; 41(4):340-4. PubMed ID: 8350495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measles surveillance in the United States: an overview.
    Guris D; Harpaz R; Redd SB; Smith NJ; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S177-84. PubMed ID: 15106108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can a minimum rate of investigation of measleslike illnesses serve as a standard for evaluating measles surveillance?
    Harpaz R; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S204-9. PubMed ID: 15106112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory surveillance for wild and vaccine-derived polioviruses - worldwide, January 2008-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(34):950-4. PubMed ID: 19730408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experiences in establishing a PEPFAR-supported laboratory quality system in Nigeria.
    Abimiku AG; Croxton T; Akintunde E; Okelade B; Jugu J; Peters S; Dakum P; Blattner W; Constantine N
    Am J Clin Pathol; 2010 Oct; 134(4):541-9. PubMed ID: 20855634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002-June 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(38):913-6. PubMed ID: 14508441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implications of the International Health Regulations (2005) for communicable disease surveillance systems: Tunisia's experience.
    Lyons S; Zidouh A; Ali Bejaoui M; Ben Abdallah M; Amine S; Garbouj M; Fitzner J
    Public Health; 2007 Sep; 121(9):690-5. PubMed ID: 17544043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Laboratory accreditation and proficiency testing].
    Kuwa K
    Rinsho Byori; 2003 May; 51(5):449-55. PubMed ID: 12806918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guidelines of the Office International des Epizooties for laboratory quality evaluation, for international reference standards for antibody assays and for laboratory proficiency testing.
    Rev Sci Tech; 1998 Aug; 17(2):600-31. PubMed ID: 9713900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress toward measles mortality reduction and elimination--Eastern Mediterranean Region, 1997-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):262-7. PubMed ID: 18340334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementing a system of enhanced surveillance for measles in Victoria. The Enhanced Measles Surveillance Working Party.
    Commun Dis Intell; 1999 Feb; 23(2):51-4. PubMed ID: 10205980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.